Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation" [Cancer Lett. (2018) 10 429 1-10.doi: 10.1016/j.canlet.2018.04.041.Epub 2018 May 5].

Cancer letters·2026
Same author

Corrigendum to "LRH1 promotes pancreatic cancer metastasis" [Cancer Lett. (2014) 24 350 (1-2) 15-24].

Cancer letters·2026
Same author

Erratum: Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architecture.

American journal of cancer research·2025
Same author

Corrigendum to "Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma" [Cancer Lett. 449 (2019) 87-98].

Cancer letters·2025
Same author

Erratum: Bio-nanoparticle based therapeutic vaccine induces immunogenic response against triple negative breast cancer.

American journal of cancer research·2025
Same author

Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.

Digestive diseases and sciences·2024

Related Experiment Video

Updated: Jun 23, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C virus and alcohol.

Larry Siu1, Julie Foont, Jack R Wands

  • 1Warren Alpert Medical School of Brown University, Providence, Rhode Island 02903, USA.

Seminars in Liver Disease
|April 24, 2009
PubMed
Summary
This summary is machine-generated.

Ethanol and chronic hepatitis C virus (HCV) infection accelerate liver injury through immune dysfunction and oxidative stress. Abstinence may improve treatment response in alcoholic patients with HCV.

More Related Videos

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Related Experiment Videos

Last Updated: Jun 23, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Area of Science:

  • Hepatology
  • Immunology
  • Toxicology

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern.
  • Alcohol abuse is common among individuals with HCV infection.
  • The interplay between ethanol and HCV infection can exacerbate liver disease progression.

Purpose of the Study:

  • To review the prevalence of HCV infection in alcoholics.
  • To examine the synergistic effects of ethanol and HCV on liver injury.
  • To elucidate the mechanisms underlying accelerated liver disease and impaired immune response.

Main Methods:

  • Review of existing literature on HCV infection, alcohol abuse, and liver disease.
  • Analysis of postulated mechanisms of disease progression, including apoptosis, oxidative stress, and immune dysfunction.
  • Examination of the impact of ethanol on immune responses, particularly dendritic cell function and T-cell activation.
  • Assessment of the relationship between alcohol consumption and response to interferon (IFN) therapy.

Main Results:

  • Ethanol and chronic HCV infection synergistically accelerate liver injury.
  • Mechanisms include increased apoptosis, lipid peroxidation, and oxidative stress, with reduced antioxidant capacity.
  • Ethanol adversely affects humoral and cellular immune responses to HCV.
  • Dendritic cell (DC) dysfunction impairs the generation of viral-specific CD4+ and CD8+ T-cell responses.
  • Increased alcohol intake is linked to decreased response to IFN therapy.

Conclusions:

  • Alcohol consumption exacerbates liver injury in patients with chronic HCV infection.
  • Ethanol-induced immune suppression, particularly DC dysfunction, contributes to disease progression.
  • Abstinence from alcohol may be crucial for improving treatment outcomes in alcoholic patients with HCV.
  • Further clinical studies are necessary to optimize treatment strategies for this patient population.